Candin for the Treatment of Common Warts

Clinical trial NCT05889845 · COMPLETED

Trial details

NCT number: NCT05889845
Sponsor: Nielsen BioSciences, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Common Warts (Verruca Vulgaris)

Start date: 2025-01-22
Primary completion: 2025-08-27
Enrollment: 330

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.